Skip to main content
Top
Published in: Medical Oncology 2/2012

01-06-2012 | Case Report

Brain metastasis from ovarian cancer: case report and review of the literature

Authors: Xi-quan Hu, Jaime Imitola, Ryan Y. Kim, Ali Mahta, Santosh Kesari

Published in: Medical Oncology | Issue 2/2012

Login to get access

Abstract

We present an 80-year-old lady with a history of ovarian cancer, who manifested with seizure and left upper extremity weakness. The imaging revealed a multilobulated mass within right parietal lobe. She underwent surgical resection and the pathology was compatible with metastasis from ovarian adenocarcinoma. She received a whole brain radiation therapy and she has been in remission for more than 2 years.
Literature
1.
go back to reference Larson DM, Copeland LJ, Moser RP, Malone JM Jr, Gershenson DM, Wharton JT. Central nervous system metastases in epithelial ovarian carcinoma. Obstet Gynecol. 1986;68:746–50.PubMed Larson DM, Copeland LJ, Moser RP, Malone JM Jr, Gershenson DM, Wharton JT. Central nervous system metastases in epithelial ovarian carcinoma. Obstet Gynecol. 1986;68:746–50.PubMed
2.
go back to reference Cohen ZR, Suki D, Weinberg JS, et al. Brain metastases in patients with ovarian carcinoma: prognostic factors and outcome. J Neurooncol. 2004;66:313–25.PubMedCrossRef Cohen ZR, Suki D, Weinberg JS, et al. Brain metastases in patients with ovarian carcinoma: prognostic factors and outcome. J Neurooncol. 2004;66:313–25.PubMedCrossRef
3.
go back to reference D’Andrea G, Roperto R, Dinia L, Caroli E, Salvati M, Ferrante L. Solitary cerebral metastases from ovarian epithelial carcinoma: 11 cases. Neurosurg Rev. 2005;28:120–3.PubMedCrossRef D’Andrea G, Roperto R, Dinia L, Caroli E, Salvati M, Ferrante L. Solitary cerebral metastases from ovarian epithelial carcinoma: 11 cases. Neurosurg Rev. 2005;28:120–3.PubMedCrossRef
4.
go back to reference Kaminsky-Forrett MC, Weber B, Conroy T, Spaeth D. Brain metastases from epithelial ovarian carcinoma. Int J Gynecol Cancer. 2000;10:366–71.PubMedCrossRef Kaminsky-Forrett MC, Weber B, Conroy T, Spaeth D. Brain metastases from epithelial ovarian carcinoma. Int J Gynecol Cancer. 2000;10:366–71.PubMedCrossRef
5.
go back to reference Pectasides D, Aravantinos G, Fountzilas G, et al. Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature. Anticancer Res. 2005;25:3553–8.PubMed Pectasides D, Aravantinos G, Fountzilas G, et al. Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature. Anticancer Res. 2005;25:3553–8.PubMed
6.
go back to reference Bruzzone M, Campora E, Chiara S, et al. Cerebral metastases secondary to ovarian cancer: still an unusual event. Gynecol Oncol. 1993;49:37–40.PubMedCrossRef Bruzzone M, Campora E, Chiara S, et al. Cerebral metastases secondary to ovarian cancer: still an unusual event. Gynecol Oncol. 1993;49:37–40.PubMedCrossRef
7.
go back to reference Ricke J, Baum K, Hosten N. Calcified brain metastases from ovarian carcinoma. Neuroradiology. 1996;38:460–1.PubMedCrossRef Ricke J, Baum K, Hosten N. Calcified brain metastases from ovarian carcinoma. Neuroradiology. 1996;38:460–1.PubMedCrossRef
8.
go back to reference Gadducci A, Tana R, Teti G, et al. Brain recurrences in patients with ovarian cancer: report of 12 cases and review of the literature. Anticancer Res. 2007;27:4403–9.PubMed Gadducci A, Tana R, Teti G, et al. Brain recurrences in patients with ovarian cancer: report of 12 cases and review of the literature. Anticancer Res. 2007;27:4403–9.PubMed
9.
go back to reference Ewend MG, Carey LA, Morris DE, Harvey RD, Hensing TA. Brain metastases. Curr Treat Options Oncol. 2001;2:537–47.PubMedCrossRef Ewend MG, Carey LA, Morris DE, Harvey RD, Hensing TA. Brain metastases. Curr Treat Options Oncol. 2001;2:537–47.PubMedCrossRef
10.
go back to reference Kolomainen DF, Larkin JM, Badran M, et al. Epithelial ovarian cancer metastasizing to the brain: a late manifestation of the disease with an increasing incidence. J Clin Oncol. 2002;20:982–6.PubMedCrossRef Kolomainen DF, Larkin JM, Badran M, et al. Epithelial ovarian cancer metastasizing to the brain: a late manifestation of the disease with an increasing incidence. J Clin Oncol. 2002;20:982–6.PubMedCrossRef
11.
go back to reference Piura B, Glezerman M, Galper Y, Segal S, Cohen Y. Brain metastases in epithelial ovarian carcinoma; two case reports. Eur J Obstet Gynecol Reprod Biol. 1990;36:203–8.PubMedCrossRef Piura B, Glezerman M, Galper Y, Segal S, Cohen Y. Brain metastases in epithelial ovarian carcinoma; two case reports. Eur J Obstet Gynecol Reprod Biol. 1990;36:203–8.PubMedCrossRef
12.
go back to reference Burt TB, Yang PJ, Gibby W. Calcified brain metastases from ovarian cancer. AJNR Am J Neuroradiol. 1988;9:613.PubMed Burt TB, Yang PJ, Gibby W. Calcified brain metastases from ovarian cancer. AJNR Am J Neuroradiol. 1988;9:613.PubMed
13.
go back to reference Heckmann JG, Tilz C, Dutsch M, Blumcke I, Hildebrandt M, Schwab S. Intracerebral hemorrhage due to metastasis of ovarian granulosa cell carcinoma 36 years after initial diagnosis. Eur Neurol. 2007;58:114–5.PubMed Heckmann JG, Tilz C, Dutsch M, Blumcke I, Hildebrandt M, Schwab S. Intracerebral hemorrhage due to metastasis of ovarian granulosa cell carcinoma 36 years after initial diagnosis. Eur Neurol. 2007;58:114–5.PubMed
14.
go back to reference Cormio G, Loizzi V, Selvaggi L. Leptomeningeal involvement after remission of brain metastases from ovarian cancer. Int J Gynaecol Obstet. 2007;99:139.PubMedCrossRef Cormio G, Loizzi V, Selvaggi L. Leptomeningeal involvement after remission of brain metastases from ovarian cancer. Int J Gynaecol Obstet. 2007;99:139.PubMedCrossRef
15.
go back to reference McMeekin DS, Kamelle SA, Vasilev SA, et al. Ovarian cancer metastatic to the brain: what is the optimal management? J Surg Oncol. 2001;78:194–200. discussion 200–191.PubMedCrossRef McMeekin DS, Kamelle SA, Vasilev SA, et al. Ovarian cancer metastatic to the brain: what is the optimal management? J Surg Oncol. 2001;78:194–200. discussion 200–191.PubMedCrossRef
16.
go back to reference Sehouli J, Pietzner K, Harter P, et al. Prognostic role of platinum sensitivity in patients with brain metastases from ovarian cancer: results of a German multicenter study. Ann Oncol 2010;21:2201–5.PubMedCrossRef Sehouli J, Pietzner K, Harter P, et al. Prognostic role of platinum sensitivity in patients with brain metastases from ovarian cancer: results of a German multicenter study. Ann Oncol 2010;21:2201–5.PubMedCrossRef
17.
go back to reference Kim TJ, Song S, Kim CK, et al. Prognostic factors associated with brain metastases from epithelial ovarian carcinoma. Int J Gynecol Cancer. 2007;17:1252–7.PubMedCrossRef Kim TJ, Song S, Kim CK, et al. Prognostic factors associated with brain metastases from epithelial ovarian carcinoma. Int J Gynecol Cancer. 2007;17:1252–7.PubMedCrossRef
18.
go back to reference Corn BW, Mehta MP, Buatti JM, et al. Stereotactic irradiation: potential new treatment method for brain metastases resulting from ovarian cancer. Am J Clin Oncol. 1999;22:143–6.PubMedCrossRef Corn BW, Mehta MP, Buatti JM, et al. Stereotactic irradiation: potential new treatment method for brain metastases resulting from ovarian cancer. Am J Clin Oncol. 1999;22:143–6.PubMedCrossRef
19.
go back to reference Monaco E 3rd, Kondziolka D, Mongia S, Niranjan A, Flickinger JC, Lunsford LD. Management of brain metastases from ovarian and endometrial carcinoma with stereotactic radiosurgery. Cancer. 2008;113:2610–4.PubMedCrossRef Monaco E 3rd, Kondziolka D, Mongia S, Niranjan A, Flickinger JC, Lunsford LD. Management of brain metastases from ovarian and endometrial carcinoma with stereotactic radiosurgery. Cancer. 2008;113:2610–4.PubMedCrossRef
Metadata
Title
Brain metastasis from ovarian cancer: case report and review of the literature
Authors
Xi-quan Hu
Jaime Imitola
Ryan Y. Kim
Ali Mahta
Santosh Kesari
Publication date
01-06-2012
Publisher
Springer US
Published in
Medical Oncology / Issue 2/2012
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-011-9876-1

Other articles of this Issue 2/2012

Medical Oncology 2/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.